Quality of life in cancer patients treated with anchored interleukin-12 (IL-12) immunotherapy: Results from a first-in-human phase 1 trial of tolododekin alfa (ANK-101).

tolododekin alfa (ANK-101) - Ankyra Therap

https://www.asco.org/abstracts-presentations/257777

Jong Chul Park; Gail Iodice; Yacine Salhi; Joseph Elassal; Howard Kaufman; Brendan Curti; Marcus Butler; John Kirkwood; Jasmine Bonsu; Isa Ngirailemesang; Russell Cheng; Leon Mcinnis; Kelly Schroder; Darcy Ploucha

Apr 21, 2026